Want to see HK:2575 full AI Analyst Report?

Xuanzhu Biopharmaceutical Co., Ltd. Class H (2575) Revenue

2 Followers

Xuanzhu Biopharmaceutical Co., Ltd. Class H Revenue

Xuanzhu Biopharmaceutical Co., Ltd. Class H had a revenue of 2.74M in the quarter ending Mar 31, 2025, with ―. This bring the company's revenue in the last twelve months to 2.74M, Decreased ―. In the fiscal year ending Dec 31, 2025, Xuanzhu Biopharmaceutical Co., Ltd. Class H had annual revenue of 56.15M with 72.08% growth.

Revenue (ttm)

2.74M

Revenue Growth

237.19%

P/S Ratio

82.47

Revenue/Employee

HK$164,175

Employees

342

Market Cap

HK$4.63B

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	56.15M	23.52M	+72.08%
Dec 31, 2024	32.63M	32.60M	+101,724.47%
Dec 31, 2023	32.04K	―	+∞%
Dec 31, 2022	―	―	―